AI Summary
- Comorbidity screening should start early, ideally at cutaneous lupus diagnosis, to detect systemic progression and cardiometabolic risk.
- Cardiovascular disease, metabolic syndrome and concurrent autoimmune conditions are common and require proactive monitoring and management.
- Employ risk stratification, patient education and multidisciplinary care to tailor screening frequency and interventions according to severity and systemic features.
J Eur Acad Dermatol Venereol. 2026 Jul 14. doi: 10.1111/jdv.70620. Online ahead of print.
NO ABSTRACT
PMID:42447180 | DOI:10.1111/jdv.70620
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
Save as PDF
⭐ My Revision List

